Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European project opens way for better understanding of human diseases

21.02.2002


In the edition of Nature dated Thursday 21 February 2002, an international team of scientists report their analysis of the genome of fission yeast (Schizosaccharomyces pombe). The project, largely funded through a €6.9 million from the European Commission, is likely to have major implications for the future of cancer and other bio-medical research. Fifty of the yeast genes were found to have significant similarity with genes involved in human diseases, including cystic fibrosis, hereditary deafness and non insulin dependent diabetes, and half were found to be cancer related. Because yeast cells are similar to human cells but easier to study, this work is leading to a better understanding of what each gene controls, and how they may be involved in cancer and other diseases in humans.



Research Commissioner Philippe Busquin commented this scientific breakthrough saying: "This type of research is yet another example for the strong link between scientic advancement and practical use for the citizen. Unlike other genomics projects, Europe has taken the leading role in this research through networking of the best. That is precisely what I have been advocating since the Lisbon summit in spring 2000, where I proposed to create a European Research Area."

Schizosaccharomyces pombe is known as fission yeast because it reproduces by splitting rather than by budding like Saccharomyces cerevisiae (baker`s yeast), and is occasionally used for brewing beer. Like man, it is an eukaryote, i.e. an organism that, unlike bacteria, contains its genome in a nucleus inside the cell and is generally thought to be more complex.


The completion of the sequence and analysis of this genome is the result of the joint effort of 13 European laboratories led by the Wellcome Trust Sanger Institute which sequenced two-thirds of the genome and did the gene predictions and annotation for all of the sequence. The global analysis of the genome was performed jointly by Cancer Research UK and the Sanger Institute. The second phase of the sequencing was carried out by a European Consortium led by the Sanger Institute. The consortium consisted of major European laboratories that also contributed to the S. cerevisiae genome project. The majority of funding for the project was from the European Commission (€6.9 million out of a total budget of €9.4 million).

The 133 authors of the Nature paper include Dr Paul Nurse of Cancer Research UK, whose work on fission yeast and cell division recently led to the award for the Nobel prize for Medicine, and Dr Bart Barrell and Val Wood from the Wellcome Trust Sanger Institute near Cambridge.

Dr Nurse stated: `Biomedicine depends on our study of model organisms, which can provide key insights into the way in which the more complex human genome works. The genome fission yeast is only the sixth higher (eukaryotic) life form to be decoded. Significantly, many decisions the humble yeast cell makes in cell division use genes that are closely related to genes implicated in many human cancers: this small organism could prove vital in helping to better understand and treat cancer and other diseases.`

Val Wood, from the Wellcome Trust Sanger Institute, commented: `Each step in our study of genomes brings new and surprising understanding of the common basis that underlies the way cells work. In this international collaboration we have provided high-quality sequence and precise analysis of the genes buried in the fission yeast genetic code, demonstrating the value of sharing genomic information. Through this shared effort, the genome of S. pombe is one of the best annotated of any non-bacterial cell. As well as finding cancer-related genes, we have begun to illustrate how other functions in this, perhaps the simplest complex cell, can bring new tools to understanding ourselves and our place in evolution.`

The joint effort to sequence and analyse the sequence of a micro-organism to better understand and improve human health is a typical an example of the continuing European effort in the area of Genomics and Biotechnology for Health. Building on such major achievements, the European Commission proposes to allocate €2.2 billion to this priority in the forthcoming Sixth Framework Programme (2002-2006).

Stéphane Hogan | alphagalileo
Further information:
http://www.sanger.ac.uk/Projects/S_pombe/

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>